High dose steroids (HDS), cyclosporine (CSA) and methotrexate (MTX) versus CSA and MTX as prophylaxis of graft versus host disease (GVHD) in HLA identical bone marrow transplantation (BMT).

被引：0
|
作者：
Macedo, MCMA [1 ]
Pallotta, RS [1 ]
Saboya, R [1 ]
Silva, RL [1 ]
Dzik, C [1 ]
Loterio, H [1 ]
Massumoto, CM [1 ]
Chamone, DAF [1 ]
Dulley, FL [1 ]
机构：
[1] UNIV SAO PAULO,SCH MED,DISCIPLINE HEMATOL,BMT PROGRAM,FUNDACAO PRO SANGUE HEMOCENTRO SAO PAULO,SAO PAULO,BRAZIL
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：417 / 417
页数：1
相关论文
共 50 条
  • [31] Comparison of standard and short course methotrexate (MTX) in combination with adjusted dose continuous infusion cyclosporin-A (CSA) to prevent acute graft versus host disease (AGVHD).
    Koc, Y
    Miller, KB
    Schenkein, DP
    Sprague, K
    Berkman, E
    BLOOD, 1997, 90 (10) : 4413 - 4413
  • [32] USE OF CAMPATH-1 AND CYCLOSPORINE-A (CSA) IN THE PROPHYLAXIS OF THE GRAFT-VERSUS-HOST DISEASE (GVHD) IN AN ALLOGENEIC BONE-MARROW TRANSPLANTATION (TMO) FOR CHRONIC MYELOID-LEUKEMIA (CML)
    ARCESE, WG
    BIANCHI, A
    MAURO, FR
    GALLERANO, T
    PASQUALETTI, D
    DEFELICE, L
    MEDICINA-RIVISTA DELLA ENCICLOPEDIA MEDICA ITALIANA, 1985, 5 (01): : 60 - 62
  • [33] Tacrolimus/methotrexate versus cyclosporine/methotrexate as graft-versus-host disease prophylaxis in patients who received bone marrow transplantation from unrelated donors
    Jaimovich, G.
    Milovic, V.
    Drelichman, G.
    Requejo, A.
    Puente, D.
    Saa, G.
    Bonini, N.
    Real, J.
    Trentadue, J.
    Feldman, L.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S145 - S145
  • [34] Mycophenolate mofetil in combination with cyclosporine a (CSA) ± prednisolone versus CsA, methotrexate ± prednisolone for the prophylaxis of acute GvHD after allogeneic stem cell transplantation -: MMF, a new option in GvHD prophylaxis.
    Kiehl, MG
    Linck, D
    Schaefer-Eckart, K
    Kroeger, M
    Bronhaeuser, M
    Blau, IW
    Wandt, H
    Jenke, A
    Kienast, J
    Armstrong, VW
    Basara, N
    Schroeder, H
    Kraut, L
    Fauser, AA
    BLOOD, 2003, 102 (11) : 716A - 716A
  • [35] CYCLOSPORINE AND METHOTREXATE (CSA/MTX) COMPARED WITH CYCLOSPORINE AND MYCOPHENOLATE MOFETIL (CSA/MMF) AS GVHD PREVENTION REGIMENS IN ALLOGENEIC STEM-CELL TRANSPLANTATION FROM UNRELATED DONORS; RELATIVE OUTCOMES ARE DEPENDANT ON DISEASE STATUS AT TRANSPLANTATION
    Shimoni, A.
    Shem-Tov, N.
    Rand, A.
    Roth, S.
    Volchek, Y.
    Yerushalmi, R.
    Nagler, A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S328 - S329
  • [36] A PROSPECTIVE RANDOMIZED TRIAL OF CYCLOSPORINE AND METHOTREXATE VERSUS CYCLOSPORINE, METHOTREXATE AND PREDNISOLONE FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER HLA-IDENTICAL SIBLING MARROW TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCY
    ATKINSON, K
    BIGGS, J
    CONCANNON, A
    DODDS, A
    YOUNG, S
    WILSON, F
    ASHBY, M
    DOWNS, K
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1991, 21 (06): : 850 - 856
  • [37] Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study
    Ruutu, T
    Volin, L
    Parkkali, T
    Juvonen, E
    Elonen, E
    BLOOD, 2000, 96 (07) : 2391 - 2398
  • [38] The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT)
    Bishara, A
    Amar, A
    Brautbar, C
    Condiotti, R
    Lazarovitz, V
    Nagler, A
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (14) : 1667 - 1675
  • [39] Multivariate analysis of pre-and post-transplant factors related to outcome in 65 consecutive allogeneic transplant patients (ALLO-BMT) receiving cyclosporine/methotrexate (CSA/MTX) as graft-vs-host-disease (GVHD) prophylaxis
    Saez, R
    Perkins, J
    Goldstein, S
    Kronish, L
    Elfenbein, G
    Partyka, J
    Ballester, O
    Sullivan, D
    Fields, K
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 322 - 322
  • [40] MICROANGIOPATHY IN PATIENTS ON CYCLOSPORINE PROPHYLAXIS WHO DEVELOPED ACUTE GRAFT-VERSUS-HOST DISEASE AFTER HLA-IDENTICAL BONE-MARROW TRANSPLANTATION
    HOLLER, E
    KOLB, HJ
    HILLER, E
    MRAZ, W
    LEHMACHER, W
    GLEIXNER, B
    SEEBER, C
    JEHN, U
    GERHARTZ, HH
    BREHM, G
    WILMANNS, W
    BLOOD, 1989, 73 (07) : 2018 - 2024
12345